Interojo Inc. (KOSDAQ:119610)
South Korea · Delayed Price · Currency is KRW 14,240
-520 (-3.52%)
Oct 29, 2026, 3:30 PM KST
Interojo Market Cap
Interojo has a market cap or net worth of 159.96 billion as of October 28, 2026. It is the 23,794th most valuable company in the world and the 958th biggest in South Korea. Its market cap has decreased by 20.04% in one year.
Market Cap
159.96B
Enterprise Value
188.47B
Revenue
124.14B
Global Rank
Country Rank
#958 South Korea
PE Ratio
9.85
ChartMarket Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 159.96B, an increase of 261.18%. That is a compound annual growth rate of 8.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 159.96B | -12.46% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.53T |
| Celltrion | 43.08T |
| ALTEOGEN | 15.21T |
| Samsung Epis Holdings | 7.75T |
| AptaBio Therapeutics | 169.40B |
| BNC KOREA | 169.28B |
| Chong Kun Dang Holdings | 168.76B |
| Daewon Pharmaceutical | 165.68B |